{"type":"trials","record":{"id":35791,"source_id":"clinicaltrials-gov","external_id":"NCT06853275","title":"The Influence of Movement Velocity Biofeedback on Muscle Activation and Self Perception in Older Adults With Sarcopenia","brief_summary":"The overall objective for this clinical trial is to provide evidence for internal and external cueing for physical therapists and other rehabilitation clinicians to optimize resistance training within rehabilitation for older adults. The main questions it aims to answer are: * What is the impact of external focus (providing velocity of movement for each repetition) compared to internal focus (i.e., no cues, control group) on physical percent velocity loss and neuromuscular activation in older adults with sarcopenia? * Does internal and external focus influence motivation and perceptual workload following resistance training in older adults with sarcopenia? Researchers will compare external focus to internal focus to see if external focus impacts percent velocity loss, motivation, and perceived workload. Participants will: * Visit the lab once per week for 3 weeks * Perform exercise testing using a leg press * Answer questionnaires regarding perceived workload and motivation before and after exercise","overall_status":"Recruiting","phases":[],"study_type":"INTERVENTIONAL","sponsor":"Creighton University","enrollment":60,"countries":["United States"],"start_date":"2025-08-01","completion_date":"2027-12-31","last_update_date":"2026-03-18","source_url":"https://clinicaltrials.gov/study/NCT06853275","editorial_summary":"A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.","first_seen_at":"2026-09-25T01:20:24.196666+00:00","last_seen_at":"2026-09-25T06:10:25.747+00:00","metadata":{"sex":"ALL","acronym":null,"age_range":"60 Years to 95 Years","comparator":null,"organization":"Creighton University","interventions":["Experimental: External Focus","Other: Internal Focus"],"registry_source":"ClinicalTrials.gov","outcome_measures":["Percent Velocity Loss — Week 1 and Week 2 Timepoints","Muscle Activation — Baseline, Week 1, and Week 2 Timepoints","Motivation — Week 1 and Week 2 Timepoints","Perceived Workload — Week 1 and Week 2 Timepoints"],"design_description":"RANDOMIZED · CROSSOVER · BASIC SCIENCE · NONE","source_has_results":false},"controlled_terms":["Sarcopenia","Sarcopenia in Elderly","Age-associated Muscle Loss","Experimental: External Focus","Other: Internal Focus"],"relevance_confidence":100,"source_quality_score":100,"freshness_score":85,"publication_state":"published","match_explanation":"Title contains controlled term: sarcopenia.","quality_checked_at":"2026-09-25T06:10:37.875473+00:00","duplicate_cluster_key":"id:nct06853275","duplicate_of_id":null,"evidence_snapshot":{"status":"structured","version":1,"duration":"2025-08-01 to 2027-12-31","comparator":null,"confidence":"structured-source","population":"ALL · 60 Years to 95 Years","provenance":{"duration":"start_date and completion_date","comparator":"registry arm fields","population":"registry eligibility fields","intervention":"registry intervention fields","participants":"enrollment","study_design":"study_type and registry design fields","evidence_stage":"phases","reported_outcome":"not available","outcomes_measured":"registry outcome-measure fields"},"generated_at":"2026-09-25T06:10:25.794Z","intervention":["Experimental: External Focus","Other: Internal Focus"],"participants":60,"study_design":"RANDOMIZED · CROSSOVER · BASIC SCIENCE · NONE","subject_scope":"Human clinical study registration","evidence_stage":"Phase not reported","safety_context":"Eligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians.","source_support":"Structured registry protocol metadata; no finding-level conclusion is generated.","main_limitation":"This is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.","reported_outcome":null,"outcomes_measured":["Percent Velocity Loss — Week 1 and Week 2 Timepoints","Muscle Activation — Baseline, Week 1, and Week 2 Timepoints","Motivation — Week 1 and Week 2 Timepoints","Perceived Workload — Week 1 and Week 2 Timepoints"],"regulatory_context":"Trial registration is not regulatory approval and does not establish that an intervention is available."},"clinical_trial_topics":[{"topic_slug":"sarcopenia","is_published":true,"match_reasons":["Title contains controlled term: sarcopenia.","Abstract contains controlled term: sarcopenia.","Source terminology contains: sarcopenia.","Title supplies longevity context: older adult.","Study type is explicitly identified as INTERVENTIONAL."],"matched_fields":["title","abstract","controlled terminology","title context","study type"],"relevance_score":100,"intelligence_topics":{"name":"Sarcopenia","slug":"sarcopenia"}}],"content_sources":{"name":"ClinicalTrials.gov","homepage_url":"https://clinicaltrials.gov/"}},"canonical_url":"https://www.immortal.life/trials/35791","automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}